Back to Journals » Drug Design, Development and Therapy » Volume 13

Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report

Total article views   HTML views PDF downloads Totals
9,995 Dovepress* 8,135+ 1,641 9,776
PubMed Central* 1,860 510 2,370
Totals 9,995 2,151 12,146
*Since 11 January 2019
Total mentioned Facebook Delicious Reddit Twitter Others
10 0 0 0 3 7

View citations on PubMed Central and Google Scholar